Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)
- DOI
- 10.1002/prp2.738
- Published
- 2021-02-28
- Container
- Pharmacology Research & Perspectives
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/prp2.738,
title = {Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)},
author = {Renan Sukmawan and Erick Hoetama and Siska Suridanda Danny and Astuti Giantini and Erlin Listiyaningsih and Vidya Gilang Rejeki and Amir Aziz Alkatiri and Isman Firdaus},
year = {2021},
journal = {Pharmacology Research \& Perspectives},
doi = {10.1002/prp2.738},
url = {https://doi.org/10.1002/prp2.738}
}RIS
TY - JOUR TI - Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI) AU - Renan Sukmawan AU - Erick Hoetama AU - Siska Suridanda Danny AU - Astuti Giantini AU - Erlin Listiyaningsih AU - Vidya Gilang Rejeki AU - Amir Aziz Alkatiri AU - Isman Firdaus PY - 2021 JO - Pharmacology Research & Perspectives DO - 10.1002/prp2.738 UR - https://doi.org/10.1002/prp2.738 ER -
APA
Sukmawan, R., Hoetama, E., Danny, S. S., Giantini, A., Listiyaningsih, E., Rejeki, V. G., Alkatiri, A. A., & Firdaus, I. (2021). Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI). Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.738
Source records
- crossref · retrieved 2026-11-10T07:46:27.673Z